We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current BMY market cap is 96.71B. The company's latest EPS is USD -4.3969 and P/E is -10.84.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 11.87B | 12.2B | 11.89B | 12.34B | 11.2B |
| Operating Income | -11.67B | 1.33B | 1.73B | 128M | 3.06B |
| Net Income | -11.91B | 1.68B | 1.21B | 72M | 2.46B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 42.52B | 46.39B | 46.16B | 45.01B | 48.3B |
| Operating Income | 3.12B | 7.87B | 7.24B | 6.91B | -8.49B |
| Net Income | -9.02B | 6.99B | 6.33B | 8.03B | -8.95B |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 99.03B | 94.65B | 93.67B | 92.6B | 92.43B |
| Total Liabilities | 82.48B | 77.58B | 76.47B | 76.22B | 74.98B |
| Total Equity | 16.55B | 17.07B | 17.2B | 16.39B | 17.45B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 118.48B | 109.31B | 96.82B | 95.16B | 92.6B |
| Total Liabilities | 80.6B | 73.31B | 65.7B | 65.67B | 76.22B |
| Total Equity | 37.88B | 36.01B | 31.12B | 29.49B | 16.39B |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 2.83B | 5.16B | 10.75B | 15.19B | 1.95B |
| Investing | -19.62B | -20.94B | -21.16B | -21.35B | -499M |
| Financing | 14.64B | 10.62B | 6.77B | 5.13B | -993M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 14.05B | 16.21B | 13.07B | 13.86B | 15.19B |
| Investing | -10.86B | -538M | -1.06B | -2.3B | -21.35B |
| Financing | -1.15B | -16.22B | -16.96B | -9.42B | 5.13B |
| Market Cap | 96.71B |
| Price to Earnings Ratio | -10.84 |
| Price to Sales Ratio | 2.01 |
| Price to Cash Ratio | 9.37 |
| Price to Book Ratio | 5.92 |
| Dividend Yield | 5.22% |
| Shares Outstanding | 2.04B |
| Average Volume (1 week) | 9.87M |
| Average Volume (1 Month) | 14.58M |
| 52 Week Change | 16.27% |
| 52 Week High | 63.33 |
| 52 Week Low | 39.925 |
| Spread (Intraday) | 0.15 (0.31%) |
| Company Name | Bristol Myers Squibb Co |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.bms.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
